Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call 22 July
Corcept Resubmits New Drug Application for Relacorilant as a Treatment for Patients with Cushing's Syndrome 17 June
Corcept Presents New Data at ADA: Improved Outcomes in Patients Receiving a GLP-1 with Difficult-to-Control Type 2 Diabetes and Hypercortisolism Treated with Korlym® 06 June
